News
Vistagen Reports Fiscal Year 2025 Third Quarter Financial Results and Corporate Update
Vistagen (Nasdaq: VTGN), a clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product
Sensorion Announces its Participation in the Association for Research in Otolaryngology ARO 48th Annual Midwinter Meeting
Regulatory News:
Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent loss
Vistagen to Report Fiscal Year 2025 Third Quarter Results and Host Corporate Update Conference Call on February 13, 2025
Vistagen (Nasdaq: VTGN), a clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product
Vistagen Receives U.S. Patent for AV-101 to Treat Neuropathic Pain
Vistagen (Nasdaq: VTGN), a clinical-stage biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders
GenSight Biologics Reports End-of-Year Cash Position and Provides Business Update
Regulatory News:
GenSight Biologics ("GenSight Biologics" or the "Company") (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing
GenSight Biologics Announces Publication of 5-Year Outcomes for Patients Treated Unilaterally with LUMEVOQ® Gene Therapy
Regulatory News:
GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal
Vistagen Announces Positive Results from Exploratory Phase 2A Study of PH284 in Cancer Cachexia
Vistagen (Nasdaq: VTGN), a late clinical-stage company dedicated to pioneering neuroscience based on nose-to-brain neurocircuitry, today announced positive results from an exploratory Phase 2A
EQS-News: Heidelberg Pharma Progresses into Cohort 7 in a Phase I/IIa Study with BCMA ATAC Candidate HDP-101 Targeting Multiple Myeloma
Vistagen Initiates Fasedienol Repeat Dose Study for the Acute Treatment of Social Anxiety Disorder
Vistagen (Nasdaq: VTGN), a late clinical-stage company dedicated to pioneering neuroscience based on nose-to-brain neurocircuitry, today announced enrollment of the first subject in a repeat dose
Newron and Myung In Pharm Announce License Agreement for evenamide in South Korea
Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for diseases of the central and peripheral nervous
Sensorion Announces Completion of Enrollment of The First Cohort of The Audiogene Phase 1/2 Gene Therapy Clinical Trial
Regulatory News:
Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within
GenSight Biologics Provides Update on Regulatory Discussions and Financial Situation
Regulatory News:
GenSight Biologics ("GenSight Biologics" or the "Company") (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing
Sensorion Reports Data in the Audiogene Phase 1/2 Gene Therapy Clinical Trial
Regulatory News:
Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss
Newron and EA Pharma (A Subsidiary of Eisai Co., Ltd.) Announce License Agreement for Evenamide in Japan and Other Asian Territories
Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral
Hol dir jetzt die Metabo Akku-Säbelsäge SSEP 18 LT BL zum Spitzenpreis!
Sichern Sie sich den CYBEX Sirona Gi i-Size Plus zum Top-Preis: Maximale Sicherheit und Komfort für Ihr Kind!
Jetzt zuschlagen: NOCO GENIUS10 - Intelligentes Batterieladegerät im Angebot!
Jetzt Zugreifen: MEGA Microsoft Xbox 360 Bauset – Dein einzigartiges Sammlerprojekt zum Sonderpreis!
Spare 11 % beim Kauf des Rowenta RH6878 X-Pert 6.60 Animal Akku-Staubsaugers – Dein neuer Reinigungsbegleiter!
Spare 52% auf den Hisense RW12D4NWG0 Weinkeller – Dein perfekter Weinlagerplatz!
Spare jetzt 29% mit dem leistungsstarken WORX Akku-Abflussreiniger!
Jetzt zugreifen: Respekta Glas Einbaubackofen autark zum Sonderpreis sichern
Entdecke den Gorenje OptiBake Advanced Einbau-Backofen: Jetzt 32% günstiger!
Kaufe den Bosch Tronic Advanced Aquastop Durchlauferhitzer – Jetzt um 49% reduziert!
Jetzt zuschlagen: Bosch Tronic Store Advanced Elektrischer Kleinspeicher zum Schnäppchenpreis!